SCHEDULE: RA Capital Boosts GH Research Stake to 12.4%

RA Capital Management and its affiliates have reported a 12.4% beneficial ownership stake in GH Research PLC, totaling 7,676,697 ordinary shares.

Summary

• RA Capital Management, L.P., Peter Kolchinsky, and Rajeev Shah collectively beneficially own 7,676,697 Ordinary Shares of GH Research PLC, representing 12.4% of the class.
• RA Capital Healthcare Fund, L.P. directly holds 7,485,080 Ordinary Shares, accounting for 12.1% of the class.
• The ownership percentage is based on 62,028,145 Ordinary Shares outstanding as of February 15, 2025, as reported in GH Research PLC's Form F-3.
• The shares are held with shared voting and shared dispositive power by the reporting persons.
• The reporting persons disclaim status as a 'group' for Schedule 13G purposes and state that the securities were not acquired or held for the purpose of changing or influencing control, other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 6

Explanation: The filing is a factual disclosure of beneficial ownership. While neutral in tone, a significant stake by a reputable investment firm like RA Capital can be perceived positively by the market as a vote of confidence in the company.

Positives

• A significant beneficial ownership stake by RA Capital Management, a prominent healthcare-focused investment firm, may signal confidence in GH Research PLC's long-term prospects.

Risks

• The filing itself does not detail specific company risks; it is a disclosure of beneficial ownership.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's future performance.

Industry Context

RA Capital Management is a well-known investment firm specializing in the healthcare and life sciences sectors. Their significant stake in GH Research PLC, a biopharmaceutical company, aligns with their investment focus on innovative healthcare companies.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake may influence investor sentiment and potentially the stock price, signaling institutional confidence.
• Management: Awareness of a large, active investor like RA Capital may influence strategic decisions, although the filing disclaims intent to influence control beyond certain nominations.

Key Dates

Keywords

GH Research PLC, RA Capital Management, Beneficial Ownership, SEC Filing, Schedule 13G, Institutional Investor, Healthcare Investment, Ordinary Shares